Quipt Home Medical Corp.

Quipt Home Medical Corp.

QIPTยทNASDAQ

$3.65

+0.0000%
HealthcareMedical - Devices

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

At a Glance

Live Snapshot
Market Cap$162.30M
EPS-0.2500
P/E Ratio-14.60
Earnings Date05/11/2026
qipt

Quipt Home Medical Corp. Street Expectations Map

QIPT ยท NASDAQ

Wall Street analysts project that QIPT stock may see slight declines over the coming 12 months. The consensus 1-year price target stands at 3.65, with estimates ranging from a low of 3.65 to a high of 3.65.

Lowest Target
3.65
0.00%
Consensus Target
3.65
0.00%
Highest Target
3.65
0.00%

The consensus 1-year price target stands at 3.65, with estimates ranging from a low of 3.65 to a high of 3.65.

Analyst Consensus Analysis

Upside Potential

0.0%

Fair value territory. Stock trading near consensus target suggests limited near-term catalysts. Focus on fundamental developments.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Moderate

Neutral sentiment. Fair value pricing with moderate agreement suggests wait-and-see approach or catalyst-driven opportunity.

Market Sentiment Insight

Efficient pricing: Stock trading at fair value with strong consensus suggests market has priced in expectations. Look for fundamental inflection points or new catalysts to drive meaningful moves.

qipt

Quipt Home Medical Corp. Forward Estimates of Revenue

QIPT ยท NASDAQ
Latest Revenue
341.40M
FY 2025
Avg Estimate
211.53M
FY 2026
Estimate Range
211.34M - 211.73M
Analyst Spread

Forward Growth Analysis

Projected Growth-38.0%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Forward Estimates of Net Income

QIPT ยท NASDAQ
Latest Net Income
-10.70M
FY 2025
Avg Estimate
-19.48M
FY 2026
Estimate Range
-19.50M - -19.46M
Analyst Spread

Forward Growth Analysis

Projected Growth-82.0%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Forward Estimates of EPS

QIPT ยท NASDAQ
Latest EPS
-0.25
FY 2025
Avg Estimate
$-0.45
FY 2026
Estimate Range
$-0.45 - $-0.45
Analyst Spread

Forward Growth Analysis

Projected Growth-80.0%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Forward Estimates of EBIT

QIPT ยท NASDAQ
Latest EBIT
-5.89M
FY 2025
Avg Estimate
-1.10M
FY 2026
Estimate Range
-1.10M - -1.10M
Analyst Spread

Forward Growth Analysis

Projected Growth+81.3%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Forward Estimates of EBITDA

QIPT ยท NASDAQ
Latest EBITDA
57.40M
FY 2025
Avg Estimate
29.94M
FY 2026
Estimate Range
29.92M - 29.97M
Analyst Spread

Forward Growth Analysis

Projected Growth-47.8%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Forward Estimates of SG&A Expense

QIPT ยท NASDAQ
Latest SG&A Expense
97.48M
FY 2025
Avg Estimate
69.60M
FY 2026
Estimate Range
69.54M - 69.66M
Analyst Spread

Forward Growth Analysis

Projected Growth-28.6%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage1 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

qipt

Quipt Home Medical Corp. Insider Positioning

QIPT ยท NASDAQ

During the last 12 months, there has been no insider trading activity reported for QIPT.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Neutral

No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.

Insider Participation

No Activity

No insider trading activity reported from any insiders in the past year.